Wheeler Bio Announces Closing Of 31 Million Series A Round Supporting Its Clinical (CGMP) Drug Substance Manufacturing Facility In Oklahoma City
Wheeler Bio, Inc., a boutique contract development and manufacturing organization (CDMO) specializing in process development and small batch CGMP...